Skip to main content
Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
237.01
-3.93 (-1.63%)
At close: Mar 6, 2026, 4:00 PM EST
241.55
+4.54 (1.92%)
After-hours: Mar 6, 2026, 6:42 PM EST

Insulet Revenue

In the year 2025, Insulet had annual revenue of $2.71B with 30.73% growth. Insulet had revenue of $783.80M in the quarter ending December 31, 2025, with 31.18% growth.

Revenue (ttm)
$2.71B
Revenue Growth
+30.73%
P/S Ratio
6.16
Revenue / Employee
$501,500
Employees
5,400
Market Cap
16.68B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.71B636.50M30.73%
Dec 31, 20242.07B374.50M22.07%
Dec 31, 20231.70B391.80M30.02%
Dec 31, 20221.31B206.50M18.79%
Dec 31, 20211.10B194.40M21.49%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Koninklijke Philips 20.94B
GE HealthCare Technologies 20.63B
Zimmer Biomet Holdings 8.23B
Smith & Nephew 6.16B
STERIS 5.83B
DexCom 4.66B
Globus Medical 2.94B
Bio-Rad Laboratories 2.58B
Revenue Rankings

PODD News

More News